Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemia.

MLA

Kobayashi, Yukio, et al. “Phase I Trial of Volasertib, a Polo-like Kinase Inhibitor, in Japanese Patients with Acute Myeloid Leukemia.” Cancer Science, vol. 106, no. 11, Nov. 2015, pp. 1590–95. EBSCOhost, https://doi.org/10.1111/cas.12814.

APA

Kobayashi, Y., Yamauchi, T., Kiyoi, H., Sakura, T., Hata, T., Ando, K., Watabe, A., Harada, A., Taube, T., Miyazaki, Y., & Naoe, T. (2015). Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemia. Cancer Science, 106(11), 1590–1595. https://doi.org/10.1111/cas.12814

Chicago

Kobayashi, Yukio, Takahiro Yamauchi, Hitoshi Kiyoi, Toru Sakura, Tomoko Hata, Kiyoshi Ando, Aiko Watabe, et al. 2015. “Phase I Trial of Volasertib, a Polo-like Kinase Inhibitor, in Japanese Patients with Acute Myeloid Leukemia.” Cancer Science 106 (11): 1590–95. doi:10.1111/cas.12814.